Filing Flows › Cerenome (CNSY) › Q2 2026 › vs Q2 2025
Cerenome (CNSY) Q2 2026 vs Q2 2025 (year over year)
Cerenome's revenue fell $979K (-70%) from $1.4M in Q2 2025 to $411K in Q2 2026.
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $411K | $1.4M | −$979K | -70% |
| Other income, net | $51K | $6.7M | −$6.6M | -99% |
| Net loss | $9.0M | −$5.2M | $14.2M | — |
| Costs & expenses | $9.5M | $8.1M | $1.4M | +17% |
| Operating costs | $9.5M | $2.9M | $6.5M | +223% |
| Research & development | $4.3M | $1.2M | $3.0M | +242% |
| General & admin | $5.2M | $1.7M | $3.5M | +209% |
| Operating cash sources | $9.0M | −$5.2M | $14.2M | — |
| Depreciation & amortization | $137K | $77K | $60K | +78% |
| Share-based compensation | $830K | $152K | $678K | +446% |
| Working capital & other | $907K | −$11.2M | $12.1M | — |
| Cash used in operations | $7.1M | $5.8M | $1.3M | +23% |
| Net loss absorbed | $9.0M | −$5.2M | $14.2M | — |
Questions
How much did Cerenome's revenue grow year over year in Q2 2026?
Cerenome's revenue fell $979K (-70%) from $1.4M in Q2 2025 to $411K in Q2 2026.